Assessing funding for AMR research in South Korea

The Research Investments in Global Health (ResIn) study were delighted to collaborate with public health researchers in South Korea (Republic of Korea) on an analysis of R&D funding related to antimicrobial resistance (AMR).

Our original article has been published in the Journal of Global Antimicrobial Resistance. We assessed 198 project reports that had a total funding of US$18.3 million. Much of the funding (61.5%) was for implementation and operational research, and universities were the lead institutions for 73.2% of the awards. There was little funding for projects that had a focus on global health, and few projects had a focus on specific pathogens.

Suggested citation –  Ryu SH, Head MG, Kim BI, Hwang JC, Cho EH. Are we investing wisely? A systematic analysis of nationally funded antimicrobial resistance projects in Korea, 2003-2013. Journal of Global Antimicrobial Resistance. 2016. doi:10.1016/j.jgar.2016.03.007

 

Tweet about this on TwitterShare on Google+Share on LinkedInShare on Facebook